The Medical Cannabis and Wellness UCITS ETF
CBDP.L
London Stock Exchange- -
GBp
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- The Medical Cannabis and Wellness UCITS ETF (ticker: CBDP.L) is an exchange-traded fund that provides investors with targeted exposure to companies involved in the medical cannabis, recreational cannabis, and wellness sectors. The ETF tracks the Hanetf Medical Cannabis and Wellness UCITS ETF Index, which includes a diversified portfolio of global equities such as cultivators, producers, distributors, pharmaceutical companies, and technology providers in the cannabis and broader wellness industries; key holdings encompass brands like Canopy Growth, Aurora Cannabis, GW Pharmaceuticals, and Cronos Group, alongside wellness-focused firms in CBD products, nutraceuticals, and health supplements. It offers physically backed replication, daily liquidity on the London Stock Exchange, and compliance with UCITS regulations for European investors, targeting institutional and retail clients seeking growth in the burgeoning cannabis market projected to expand amid regulatory liberalization in North America, Europe, and Israel. Launched in 2019 by HANetf, a London-based ETF platform provider founded in 2017 with headquarters in the United Kingdom, the fund operates geographically across North America (primarily Canada and the U.S.), Europe, and select emerging markets. HANetf serves as the issuer and promoter, partnering with global market makers for efficient trading; the fund has no parent company but collaborates with index provider Hanetf and custodians like BNP Paribas. In recent developments within the last two years, the ETF benefited from regulatory tailwinds including Germany's partial cannabis legalization in April 2024 and U.S. rescheduling discussions in 2024-2025 under President Trump's administration, driving inflows and performance gains; it also saw a strategic index rebalance in mid-2025 to incorporate new wellness sub-sectors like psychedelics and functional mushrooms amid rising investor interest. No major acquisitions or name changes have occurred, but HANetf expanded its UCITS ETF suite with complementary thematic funds, enhancing distribution through partnerships with platforms like Hargreaves Lansdown and Interactive Brokers.